CALASIA PHARMACEUTICALS INC has a total of 12 patent applications. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PAINCEPTOR PHARMA CORP, MOUNT COOK BIOSCIENCES INC and KOCHI MUTSUYUKI.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Prasad Sridhar G | 9 |
#2 | Natala Srinivasa Reddy | 5 |
#3 | Cosford Nicholas | 4 |
#4 | Collins Bernard | 2 |
#5 | De Surya Kanta | 1 |
#6 | Prasad G Sridhar | 1 |
#7 | G Sridhar Prasad | 1 |
#8 | Marshall Clarke Peterman | 1 |
#9 | Peterman Marshall | 1 |
#10 | Prasad G | 1 |
Publication | Filing date | Title |
---|---|---|
EP3773438A2 | Pharmacological agents for treating ocular diseases | |
WO2016040807A1 | Pyrimidine-diamine dual hsp90/trap1 inhibitors | |
AU2013263420A1 | Pyrimidine diamine derivatives as inhibitors of cytosolic Hsp90 |